do glp 1 increase insulin GLP-1 is released from the small intestine after meal ingestion and 🧬 GLP-1 medications were developed

Liu J, Kang R, Tang D

G., Sallese, M., Antonucci, I., Aleksandr Trofimov, Vladimir Khavinson, Trofimova, S., Bruno, A., & Ballerini, P

In vitro treatment of a murine mammary adenocarcinoma cell line with recombinant Trypanosoma cruzi calreticulin promotes immunogenicity and phagocytosis

New capillary formation into damaged tissue eNOS Nitric Oxide System BPC-157 modulates nitric oxide synthesis via endothelial NOS (eNOS) and inducible NOS (iNOS) in a context-dependent, bidirectional manner increasing NO when protective perfusion is needed, decreasing it when excess NO is driving chronic inflammation or cytotoxic damage

GLP-1 receptors sit throughout the body, in the brain, pancreas, heart, and blood vessels, and the drugs appear to reduce inflammation and the organ-damaging fat that drives much metabolic harm

But what exactly is an agonist, and why is Retatrutide causing such a stir